- Home
- LYEL vs SUIG Comparison
LYEL vs SUIG Comparison
Compare LYEL & SUIG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LYEL
- SUIG
- Stock Information
- Founded
- LYEL 2018
- SUIG 2006
- Country
- LYEL United States
- SUIG United States
- Employees
- LYEL N/A
- SUIG N/A
- Industry
- LYEL Biotechnology: Pharmaceutical Preparations
- SUIG Finance Companies
- Sector
- LYEL Health Care
- SUIG Finance
- Exchange
- LYEL Nasdaq
- SUIG Nasdaq
- Market Cap
- LYEL 253.2M
- SUIG 270.0M
- IPO Year
- LYEL 2021
- SUIG N/A
- Fundamental
- Price
- LYEL $17.75
- SUIG $2.50
- Analyst Decision
- LYEL Hold
- SUIG Strong Buy
- Analyst Count
- LYEL 3
- SUIG 2
- Target Price
- LYEL $16.67
- SUIG $5.75
- AVG Volume (30 Days)
- LYEL 27.0K
- SUIG 1.7M
- Earning Date
- LYEL 11-12-2025
- SUIG 11-13-2025
- Dividend Yield
- LYEL N/A
- SUIG N/A
- EPS Growth
- LYEL N/A
- SUIG 619.34
- EPS
- LYEL N/A
- SUIG 0.24
- Revenue
- LYEL $60,000.00
- SUIG $3,305,884.00
- Revenue This Year
- LYEL N/A
- SUIG N/A
- Revenue Next Year
- LYEL N/A
- SUIG N/A
- P/E Ratio
- LYEL N/A
- SUIG $10.46
- Revenue Growth
- LYEL 11.11
- SUIG 1.77
- 52 Week Low
- LYEL $7.65
- SUIG $1.13
- 52 Week High
- LYEL $30.00
- SUIG $8.66
- Technical
- Relative Strength Index (RSI)
- LYEL 59.71
- SUIG N/A
- Support Level
- LYEL $15.77
- SUIG N/A
- Resistance Level
- LYEL $17.75
- SUIG N/A
- Average True Range (ATR)
- LYEL 1.15
- SUIG 0.00
- MACD
- LYEL -0.18
- SUIG 0.00
- Stochastic Oscillator
- LYEL 69.86
- SUIG 0.00
About LYEL Lyell Immunopharma Inc.
Lyell Immunopharma Inc is a clinical-stage cell therapy company. It has a pipeline of product candidates for patients with solid tumors utilizing ex vivo genetic and epigenetic T-cell reprogramming technologies. The company's product pipeline includes, LYL797, LYL119, LYL845 among others.
About SUIG Sui Group Holdings Limited Common Stock
Sui Group Holdings Ltd is a non-bank lender and specialty finance company. The company is engaged in the business of providing short-term specialty finance solutions to private businesses, micro-and small-cap public companies, and high-net-worth individuals. The principal specialty finance solutions that the group provides are high-interest short-term lending arrangements. Typically, these lending arrangements involve obtaining collateral as security for the borrower's repayment of funds, or personal guarantees from the principals or affiliates of the borrower.